The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy).

Abstract : Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components of this inflammatory process in P-NALD remain elusive. In this study, we used transcriptomic profiling and PCR array analyses to explore inflammatory gene expression in patient fibroblasts. Our results show the activation of IL-1 inflammatory pathway accompanied by the increased secretion of two IL-1 target genes, IL-6 and IL-8 cytokines. Human fibroblasts exposed to very-long-chain fatty acids exhibited increased mRNA expression of IL-1α and IL-1β cytokines. Furthermore, expression of IL-6 and IL-8 cytokines in patient fibroblasts was down-regulated by MAPK, p38MAPK, and Jun N-terminal kinase inhibitors. Thus, the absence of acyl-coenzyme A oxidase 1 activity in P-NALD fibroblasts triggers an inflammatory process, in which the IL-1 pathway seems to be central. The use of specific kinase inhibitors may permit the modulation of the enhanced inflammatory status.
Type de document :
Article dans une revue
Endocrinology, Endocrine Society, 2012, 153 (6), pp.2568-75. 〈10.1210/en.2012-1137〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00692894
Contributeur : Stéphane Mandard <>
Soumis le : vendredi 12 avril 2013 - 17:41:28
Dernière modification le : dimanche 11 février 2018 - 01:14:33
Document(s) archivé(s) le : samedi 13 juillet 2013 - 02:35:09

Fichiers

inserm-00692894_edited.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Hammam El Hajj, Aurore Vluggens, Pierre Andreoletti, Kevin Ragot, Stéphane Mandard, et al.. The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy).. Endocrinology, Endocrine Society, 2012, 153 (6), pp.2568-75. 〈10.1210/en.2012-1137〉. 〈inserm-00692894〉

Partager

Métriques

Consultations de la notice

451

Téléchargements de fichiers

1405